Nektar Therapeutics (NKTR): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 141,4 US Dollar | 9 | 1 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 34.142.994 | 18,52 | 8,82 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Nektar Therapeutics
Mitarbeiter 63
Handelsplatz NASDAQ
Ticker Symbol NKTR
IPO Datum 1994-05-03
Adresse 455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158
Webseite https://www.nektar.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Howard W. Robin | CEO, President & Director |
| 2 | Dr. Jonathan Zalevsky Ph.D. | Senior VP and Chief Research & Development Officer |
| 3 | Ms. Linda M. Rubinstein M.A. | CFO and Principal Financial & Accounting Officer |
| 4 | Mr. Jason Barnard | Chief Accounting Officer |
| 5 | Ms. Elizabeth Zhang | VP of Legal, Corporate Counsel & Secretary |
| 6 | Mr. Spilios Asimakopoulos | Vice President of Commercial Strategy & Marketing |
| 7 | Mr. Robert Bacci | Chief People Officer and Head of Quality & Facilities |
| 8 | Ms. Jennifer Ruddock | Chief Business Officer |
| 9 | Dr. Mary Tagliaferri L.Ac., M.D. | Chief Medical Officer |
| 10 | Dr. Ken Franke Ph.D. | Senior Vice President of Biologics Process Development & Manufacturing |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 14,84% | 0,21 Mrd. USD |
| 2 | BlackRock Inc | 8,62% | 0,12 Mrd. USD |
| 3 | Bvf Inc | 7,00% | 0,10 Mrd. USD |
| 4 | Two Seas Capital LP | 5,74% | 0,08 Mrd. USD |
| 5 | Vanguard Capital Management, LLC | 4,38% | 0,06 Mrd. USD |
| 6 | Two Sigma Investments LLC | 3,52% | 0,05 Mrd. USD |
| 7 | Vestal Point Capital LP | 2,93% | 0,04 Mrd. USD |
| 8 | Morgan Stanley - Brokerage Accounts | 2,74% | 0,04 Mrd. USD |
| 9 | State Street Corp | 2,66% | 0,04 Mrd. USD |
| 10 | Geode Capital Management, LLC | 2,58% | 0,04 Mrd. USD |
| 11 | Prosight Management, LP | 2,37% | 0,03 Mrd. USD |
| 12 | Armistice Capital, LLC | 2,12% | 0,03 Mrd. USD |
| 13 | Gilder Gagnon Howe & CO LLC | 1,76% | 0,03 Mrd. USD |
| 14 | Millennium Management LLC | 1,40% | 0,02 Mrd. USD |
| 15 | BRAIDWELL LP | 1,39% | 0,02 Mrd. USD |
| 16 | Sofinnova Ventures | 1,38% | 0,02 Mrd. USD |
| 17 | Woodline Partners LP | 1,38% | 0,02 Mrd. USD |
| 18 | Orbimed Advisors LLC | 1,36% | 0,02 Mrd. USD |
| 19 | UBS Group AG | 1,25% | 0,02 Mrd. USD |
| 20 | Emerald Advisers, LLC | 1,14% | 0,02 Mrd. USD |